CE-VST01-JC

N/A

Report date: 2025/01/26 17:52:47

Base Information

Drug NameCE-VST01-JC
Drug Alias NameJC virus specific T-cell therapy (Cellevolve Bio)JCPyV-specific allogeneic T-cell therapy (Cellevolve Bio)CE-VST01-JC
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellevolve Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellevolve Bio Inc
Inactive CompaniesN/A
Active IndicationsLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A